Medical thoracoscopy with talc poudrage for pneumothorax in patients with chronic obstructive pulmonary disease

A. W. K. Ng, P. Lee (Singapore, Singapore)

Source: Annual Congress 2001 - Thoracoscopy
Session: Thoracoscopy
Session type: Oral Presentation
Number: 3480

Congress or journal article abstract

Abstract

Introduction: Pneumothorax (PT) is an important cause of morbidity in patients with chronic obstructive pulmonary disease (COPD). Following relief of PT with tube thoracostomy, pleurodiesis is usually performed to prevent a recurrence. We studied the effectiveness of medical thoracoscopy (MT) with talc poudrage in the management of PT in patients with COPD.
Material and Methods: Clinical records of patients with PT and COPD who had undergone MT were reviewed. The procedure was performed through a single point of entry, under local anaesthesia and light sedation in the endoscopy suite; up to 5g of sterile talc was insufflated for pleurodiesis. The intercostal tube was removed upon cessation of air-leak.
Results: 28 patients (26M:2F) with a mean age of 71.8±]7.5 years were treated. Mean FEV1 was 45.6±]12.7% of predicted. In 9, PT was recurrent and pleurodiesis attempted before. After MT, 11 patients (39%) experienced pain, 4 (14%) had fever and 19 (68%) had subcutaneous emphysema of varying degree, which subsided without further intervention. The air-leak exceeded 7 days in 9; the interval to chest tube removal 7.2±]6.2 days. Two patients developed pneumonia during the hospitalisation. 2 patients (FEV130% & 40% predicted) died from severe exacerbation of COPD within 2 weeks of procedure. There was no recurrence at 12 months post-procedure.
Conclusion: MT with talc poudrage is a safe and effective method of pleurodiesis for patients with PT and impaired lung function from COPD.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. W. K. Ng, P. Lee (Singapore, Singapore). Medical thoracoscopy with talc poudrage for pneumothorax in patients with chronic obstructive pulmonary disease. Eur Respir J 2001; 16: Suppl. 31, 3480

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Air travel and anaesthesia in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=451
Year: 2006

VATS or simple talc poudrage under medical thoracoscopy for recurrent spontaneous pneumothorax
Source: Eur Respir J 2009; 33: 442-443
Year: 2009


Indications and results of surgical pleurodesis for spontaneous pneumothorax
Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today
Year: 2007



Pneumothorax secondary to chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012

Association between antifibrotic medications and pneumothorax or pneumomediastinum in patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Surgical treatment of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=359
Year: 2006

Video-assisted medical thoracoscopic (VAMT) lung biopsy in the diagnosis of diffuse pulmonary infiltrates
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015


Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study
Source: Eur Respir J 2011; 38: 770-773
Year: 2011



Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Source: Eur Respir J 2013; 41: 302-308
Year: 2013



Propofol sedation for flexible bronchoscopy in patients with and without chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013

Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Source: Eur Respir J 2007; 29: 757-760
Year: 2007



Diagnostic thoracoscopy in suspected malignant disease of the pleura: Pleural nodularity justifies talc poudrage
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Bronchoscopic management of obstructive lung disease
Source: ERS Course: Interventional bronchoscopy
Year: 2019

Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis
Source: Eur Respir J 2002; 20: 777-784
Year: 2002



Complications after bullectomy in patients with generalized emphysema
Source: Eur Respir J 2003; 22: Suppl. 45, 370s
Year: 2003

Talc pleurodesis by thoracoscopy in patients with primary spontaneous pneumothorax: a 10-year experience.
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019

Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008


Predictors of invasive mechanical ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD and weaning
Year: 2017

Management of secondary tension pneumothorax as a complication of chronic obstructive pulmonary disease: self-experience study
Source: International Congress 2018 – Pleural effusions, infections and tumours
Year: 2018

Diagnostic value of video-assisted thoracoscopic lung biopsy on diagnosis of diffuse parenchymal lung dissease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013